BioLife4D Corporation (SAVU)

BioLife4D Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	0.44	0.93	0.33
Cash & Cash Equivalents	0.44	0.93	0.33
Cash Growth	-	180.07%	-
Other Current Assets	0	0.03	0.01
Total Current Assets	0.45	0.96	0.34
Property, Plant & Equipment	-	0.01	0.01
Other Long-Term Assets	-	0.02	0
Total Long-Term Assets	-	0.02	0.02
Total Assets	-	0.98	0.36
Accounts Payable	-	0	-
Other Current Liabilities	0.44	0.08	0.03
Total Current Liabilities	0.44	0.09	0.03
Long-Term Debt	-	0.75	0.9
Other Long-Term Liabilities	-	0.14	0.09
Total Long-Term Liabilities	-	0.88	1
Total Liabilities	-	0.97	1.02
Total Debt	1.02	0.75	0.9
Debt Growth	-	-17.66%	-
Retained Earnings	-	-6.61	-5.11
Shareholders' Equity	-0.62	0.01	-0.66
Net Cash / Debt	-0.58	0.19	-0.57
Working Capital	0	0.87	0.32

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).